PBMs’ ‘Perverse Incentives’ Still Limiting Generics Access, AAM Report Reiterates
Supply Chain Middlemen Continue To Block Patient Access To Cheaper Generic Drugs
Many patients are unable to access cheaper generics due to formulary decisions • Source: Shutterstock 
